SRC-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathway

被引:0
作者
Ying Wang
Xia Luo
Nayiyuan Wu
Qianjin Liao
Jing Wang
机构
[1] Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine,
[2] Central South University,undefined
来源
Medical Oncology | / 40卷
关键词
SRC-3; Ovarian cancer; Stemness; Migration; Invasion;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 69 条
[1]  
Tew WP(2016)Ovarian cancer in the older woman J Geriatr Oncol 7 354-61
[2]  
Ottevanger PB(2017)Ovarian cancer stem cells more questions than answers Semin Cancer Biol 44 67-71
[3]  
Lee J(2016)Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells Int J Oncol 49 1945-52
[4]  
Schorge JO(2010)Surgical debulking of ovarian cancer: what difference does it make? Rev Obstet Gynecol 3 111-117
[5]  
McCann C(2017)Solute carrier family 39 member 6 gene promotes aggressiveness of esophageal carcinoma cells by increasing intracellular levels of zinc, activating phosphatidylinositol 3-kinase signaling, and up-regulating genes that regulate metastasis Gastroenterology 152 1985-97.e12
[6]  
Del Carmen MG(2018)Advances in ovarian cancer therapy Cancer Chemother Pharmacol 81 17-38
[7]  
Cheng X(2019)Ovarian cancer stem cells and targeted therapy J Ovarian Res 12 120-51
[8]  
Cortez AJ(2019)Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells Cancer Cell Int 19 330-403
[9]  
Keyvani V(2020)Prophylactic salpingectomy for the prevention of ovarian cancer: who should we target? Int J Cancer 147 1245-9
[10]  
Wang J(2011)Abagovomab for ovarian cancer Expert Opin Biol Ther 11 395-64